Aurora Spine Corporation: FIRST SURGICAL IMPLANT OF ZIP ULTRA(TM) MIS INTERSPINOUS DEVICE PERFORMED IN ISRAEL
Carlsbad, California, October 31, 2014 /Marketwired/ – Aurora Spine Corporation
(TSXV:ASG) announced today the first surgical implant of the company’s ZIP ULTRA(TM) Minimally Invasive interspinous device in Israel. Multiple surgeries have now been performed at the Herzliya Medical Center by Prof. Reuven Gepstein.
“The ZIP ULTRA MIS fusion system is a very intuitive and easy to use system that allows me to perform a short and safe surgery while avoiding the risk of nerve impact,” said Prof. Gepstein. “The surgery was performed under local anesthesia, was quick with minimal pain and the patient’s recovery time is expected to be extremely rapid.”
“We are very excited that Aurora now offers our ZIP MIS system portfolio in Israel,” said Trent Northcutt, President and Chief Executive Officer of Aurora Spine. “We believe that the ZIP ULTRA MIS fusion system will change spine surgery with a true minimally invasive approach designed to achieve reproducible, superior patient outcomes.”
Aurora Spine’s ZIP Ultra MIS interspinous fixation implant for spinal fusion, consists of a ONE-STEP(TM) locking mechanism, articulating spikes and various sizes to accommodate variations in patient anatomy which eliminates the use of a set screw.
About Aurora Spine
Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.
Forward-Looking Statements
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Information” in Aurora Spine’s final prospectus (collectively, “forward-looking information”). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine’s securities about important factors that could cause Aurora Spine’s actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
For more information, please contact:
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Eric Fronk
Chief Financial Officer
(760) 424-2004
